Research programme: immunoregulatory vaccines - igeneon
Alternative Names: IGN-501; Immunoregulatory vaccines research programme - igeneonLatest Information Update: 05 Nov 2009
At a glance
- Originator igeneon Krebs-Immuntherapie Forschungs- und Entwicklungs-AG
- Class Vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Autoimmune disorders; Cancer; Hypersensitivity
Most Recent Events
- 05 Nov 2009 Discontinued - Preclinical for Allergy in Austria (unspecified route)
- 05 Nov 2009 Discontinued - Preclinical for Autoimmune disorders in Austria (unspecified route)
- 05 Nov 2009 Discontinued - Preclinical for Cancer in Austria (unspecified route)